New data indicate that nonoperative surveillance after removing a malignant colorectal polyp can achieve high rates of rectal ...

A retrospective study of patients with distal rectal cancer at Memorial Sloan Kettering Cancer Center (MSK) has found a higher rate of local recurrence after intersphincteric resection with handsewn ...

Clinical results have been announced for a treatment that allows rectal cancer patients to achieve long-term survival without ...

Neoadjuvant radiotherapy followed by surgery can improve overall survival compared with surgery alone in certain patients with locally advanced rectal cancers, most notably in those with lower rectal ...

The treatment of patients with localized rectal cancer is complex and requires input from a multidisciplinary team. Baseline local staging and mismatch repair protein testing are vital to develop ...

Patients with locally advanced rectal cancer treated with FOLFOX before surgery had similar outcomes and side effect profiles to those treated with presurgical pelvic chemoradiation. Patients with ...

Neoadjuvant therapy with immunotherapy in pMMR/MSS rectal cancer shows high response rates and favorable surgical outcomes, with manageable safety profiles. Short-course chemoradiotherapy demonstrates ...

Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required. To avoid life-altering ...